Related references
Note: Only part of the references are listed.Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction
Indika Edirisinghe et al.
FASEB JOURNAL (2008)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Rheumatoid arthritis: Diagnosis and management
Vikas Majithia et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases
Richard O. Williams et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Nikoletta Rovina et al.
RESPIRATORY RESEARCH (2007)
Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts
Alice P. Taylor et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Impaired TNF alpha-induced VEGF expression in human airway smooth muscle cells from smokers with COPD: Role of MAPkinases and histone acetylation-effect of dexamethasone
Maria Raidl et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2007)
VEGF/VEGFR signalling as a target for inhibiting angiogenesis
Alex Kiselyov et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Interaction of vascular endothelial growth factor 165 with neuropilin-1 protects rheumatoid synoviocytes from apoptotic death by regulating Bcl-2 expression and Bax translocation
Wan-Uk Kim et al.
JOURNAL OF IMMUNOLOGY (2006)
Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages
Masato Murakami et al.
BLOOD (2006)
Vascular endothelial growth factor signaling pathways: Therapeutic perspective
Marcin Kowanetz et al.
CLINICAL CANCER RESEARCH (2006)
Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways
ML Cho et al.
IMMUNOLOGY LETTERS (2006)
IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes
S Ryu et al.
CLINICAL RHEUMATOLOGY (2006)
Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-α and IL-6 by human monocytes
SA Yoo et al.
JOURNAL OF IMMUNOLOGY (2005)
Anti-Flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis
DG Bae et al.
CLINICAL CANCER RESEARCH (2005)
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
N Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis
M De Bandt et al.
JOURNAL OF IMMUNOLOGY (2003)
Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis
AW Mould et al.
ARTHRITIS AND RHEUMATISM (2003)
Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor
SK Selvaraj et al.
BLOOD (2003)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
M Autiero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Evolving concepts of rheumatoid arthritis
GS Firestein
NATURE (2003)
A critical role of placental growth factor in the induction of inflammation and edema formation
H Oura et al.
BLOOD (2003)
Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain
R Mamluk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts
ML Cho et al.
ARTHRITIS AND RHEUMATISM (2002)
Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells
TH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice
H Sone et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
J Miotla et al.
LABORATORY INVESTIGATION (2000)
CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor
CS Cho et al.
JOURNAL OF IMMUNOLOGY (2000)
Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid
MJ Bottomley et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)